Potential effect of coenzyme Q10 (Ubiquinone) on serum NGAL biomarker and kidney function following Coronary Artery Bypass Grafting surgery
Journal of Cellular & Molecular Anesthesia,
Vol. 5 No. 2 (2020),
21 July 2020
,
Page 59-66
https://doi.org/10.22037/jcma.v5i2.29975
Abstract
Background: Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG) surgery, and is associated with major adverse outcomes. Effect of preoperative administration of coenzyme Q10 was evaluated in order to realize that whether it could prevent the occurrence of AKI following elective CABG surgery. Materials and Methods: Two hundred and fifty patients who were candidate for elective CABG surgery between September 2017 and August 2018 were randomly assigned to intervention group (receiving coenzyme Q10, 300 mg BID for 2 days before surgery) and control group. Serum NGAL (neutrophil gelatinase-associated lipocalin) was measured at baseline, 6 and 24 hours after surgery. Serum creatinine (sCr) and urine output (UO) were also measured at baseline and after surgery. Results: Fifty patients completed the study. The total incidence of acute kidney injury was 32%. There were no significant differences in the incidence of AKI (p=0.07) between the two groups. Serum NGAL was shown no significant difference at 6 (p=0.13) and 24 (p=0.22) hours after surgery compared to the baseline level between the two groups, whereas, the significant difference in the hospitalization duration was shown between them (p=0.02). Conclusion: CoQ10 supplementation did not significantly decrease the incidence of AKI in patients undergoing elective CABG.- ubiquinone
- co-enzyme Q10
- Acute Kidney Injury
- Coronary Artery Bypass Grafting Surgery
- neutrophil gelatinase-associated lipocalin protein
How to Cite
References
Lysak N, Bihorac A, Hobson C. Mortality and cost of acute and chronic kidney disease after cardiac surgery. Curr Opin Anaesthesiol. 2017;30(1):113-7.
Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81(9):819-25.
Thakar CV, Yared J-P, Worley S, Cotman K, Paganini EP. Renal dysfunction and serious infections after open-heart surgery. Kidney international. 2003;64(1):239-46.
J W Sear. Kidney Dysfunction in the Postoperative Period. Br J Anaesth. 2005;95(1):20-32.
Chen H, Busse LW. Novel Therapies for Acute Kidney Injury. Kidney Int Rep. 2017;2(5):785-99.
Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant Mechanisms in Renal Injury and Disease. Antioxid Redox Signal. 2016;25(3):119-46.
Dennis JM, Witting PK. Protective Role for Antioxidants in Acute Kidney Disease. Nutrients. 2017;9(7): 718.
Honore PM, Jacobs R, Hendrckx I, Spapen HD. Statins barely touch the heart but bite the kidneys after cardiac surgery. Coenzyme Q10 deficiency in the dock? Ann Transl Med. 2016;4(Suppl 1):S48.
Mantle D, Hargreaves I. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. Antioxidants (Basel). 2019;8(2): 44.
de Frutos F, Gea A, Hernandez-Estefania R, Rabago G. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2015;20(2):254-9.
Flume PA, Mogayzel Jr PJ, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180(9):802-8.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
Eggerbauer E, de Benedictis P, Hoffmann B, Mettenleiter TC, Schlottau K, Ngoepe EC, et al. Evaluation of six commercially available rapid immunochromatographic tests for the diagnosis of rabies in brain material. PLoS Negl Trop Dis. 2016;10(6):e0004776.
Harty J. Prevention and Management of Acute Kidney Injury. Ulster Med J. 2014;83(3):149-57..
Adabag A, Ishani A, Koneswaran S, Johnson D, Kelly R, Ward H, et al. Utility of N-acetylcysteine to kidney injury after cardiac surgery: A randomized controlled trial. Am Heart J. 2008;155(6):1143-9.
Patel NN, Rogers CA, Angelini GD, Murphy GJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16(6):553-67.
Amini S, Robabi HN, Tashnizi MA, Vakili V. Selenium, Vitamin C and N-Acetylcysteine do not Reduce the Risk of Acute Kidney Injury after Off-Pump CABG: a Randomized Clinical Trial. Braz J Cardiovasc Surg. 2018;33(2):129-134.
Iglesias P, Selgas R, Romero S, Diez JJ. Selenium and kidney disease. J Nephrol. 2013;26(2):266-72.
Veighey K, MacAllister R. Clinical applications of remote ischaemic preconditioning in native and transplant acute kidney injury. Pediatr Nephrol. 2015;30(10):1749-59.
Makris K, Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev. 2016; 37(2):85-98.
Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19-32.
Zhang J, Han J, Liu J, Liang B, Wang X, Wang C. Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury. Exp Ther Med. 2017;14(5):5017-21.
Dastan F, Talasaz AH, Mojtahedzadeh M, Karimi A, Salehiomran A, Bina P, et al. Semin Thorac Cardiovasc Surg. Spring 2018;30(1):7-13.
Ronco C. Biomarkers for acute kidney injury: is NGAL ready for clinical use? Crit Care. 2014;18(6):680.
Carrasco J, Anglada FJ, Campos JP, Muntane J, Requena MJ, Padillo J. The protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: a randomised, placebo-controlled clinical trial. BJU Int. 2014;113(6):942-50.
Takenaka M, Tatsukawa Y, Dohi K, Ezaki H, Matsukawa K, Kawasaki T. Protective Effects of Alpha-Tocopherol and Coenzyme Q10 on Warm Ischemic Damages of the Rat Kidney. Transplantation. 1981;32(2):137-41.
Lass A, Forster MJ, Sohal RS. Effects of Coenzyme Q10 and Alpha-Tocopherol Administration on Their Tissue Levels in the Mouse: Elevation of Mitochondrial Alpha-Tocopherol by Coenzyme Q10. Free Radic Biol Med. 1999;26(11-12):1375-82.
Ustuner MA, Kaman D, Colakoglu N. Effects of benfotiamine and coenzyme Q10 on kidney damage induced gentamicin. Tissue Cell. 2017;49(6):691-6.
Ishikawa A, Kawarazaki H, Ando K, Fujita M, Fujita T, Homma Y. Renal preservation effect of ubiquinol, the reduced form of coenzyme Q10. Clin Exp Nephrol. 2011;15(1):30-3.
Signorini L, Granata S, Lupo A, Zaza G. Naturally occurring compounds: new potential weapons against oxidative stress in chronic kidney disease. Int J Mol Sci. 2017;18(7):1481.
Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, et al. Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial. Am J Kidney Dis. 2017 Mar;69(3):389-99.
Zahed N. S, Ghassami M, Nikbakht H. Effects of coenzyme Q10 supplementation on C-reactive protein and homocysteine as the inflammatory markers in hemodialysis patients; a randomized clinical trial. J Nephropathol. 2016;5(1):38-43.
Chen F, Liu F, Lu J, Yang X, Xiao B, Jin Y, et al. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study. Eur J Med Res. 2018;23(1):23.
Dastan F, Talasaz AH, Mojtahedzadeh M, Karimi A, Salehiomran A, Bina P, et al. Potential effect of L-carnitine on the prevention of myocardial injury after coronary artery bypass graft surgery. J Tehran Heart Cent. 2015;10(2):74-9.35.
Jahangirifard A, Salajegheh S, Arab S, Mirtajani SB, Farzanegan B. Thiamine could decrease Lactate and Creatinine level after Coronary Artery Bypass Surgery in Patients with Mild Systolic Dysfunction. J Cell Mol Anesth. 2018;3(4):136-42.
- Abstract Viewed: 250 times
- PDF Downloaded: 181 times